Clinical Trial Update: Phase I/II Study of Weekly Abraxane and RAD001 in Women With Locally Adv. or Metastatic Breast Ca [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/II study evaluating weekly Abraxane (paclitaxel protein-bound) plus RAD001 (everolimus) in women with locally advanced or metastatic breast cancer was…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• RAD001 (everolimus)

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2022-11-07